Works matching IS 00099236 AND DT 2025 AND VI 117 AND IP 1
Results: 34
Highlighted Articles.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 14, doi. 10.1002/cpt.3490
- Publication type:
- Article
Correction to Beyond MABEL: An Integrative Approach to First in Human Dose Selection of Immunomodulators by the Health and Environmental Sciences Institute (HESI) Immuno‐Safety Technical Committee (ITC).
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 310, doi. 10.1002/cpt.3489
- Publication type:
- Article
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 9, doi. 10.1002/cpt.3488
- Publication type:
- Article
First‐in‐Human Dose Selection for T‐Cell Engaging Bispecific Antibodies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 11, doi. 10.1002/cpt.3487
- By:
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 16, doi. 10.1002/cpt.3486
- Publication type:
- Article
Correction to: Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney Disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 309, doi. 10.1002/cpt.3483
- Publication type:
- Article
Narrow Therapeutic Index Drugs: FDA Experience, Views, and Operations.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 116, doi. 10.1002/cpt.3460
- By:
- Publication type:
- Article
Harnessing Pharmacogenomics in Clinical Research on Psychedelic‐Assisted Therapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 106, doi. 10.1002/cpt.3459
- By:
- Publication type:
- Article
Value of Pharmacogenetic Testing Assessed with Real‐World Drug Utilization and Genotype Data.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 278, doi. 10.1002/cpt.3458
- By:
- Publication type:
- Article
New Drug Development Strategy in Japan: Flexibility in Guideline Adherence.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 270, doi. 10.1002/cpt.3456
- By:
- Publication type:
- Article
Prediction of Cardiac ATTR Depletion by NI006 (ALXN2220) Using Mechanistic PK/PD Modeling.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 261, doi. 10.1002/cpt.3455
- By:
- Publication type:
- Article
Sex‐Dependent Effects of CYP2D6 on the Pharmacokinetics of Berberine in Humans.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 250, doi. 10.1002/cpt.3454
- By:
- Publication type:
- Article
Correction to Effectively Leveraging RWD for External Controls: A Systematic Literature Review of Regulatory and HTA Decisions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 289, doi. 10.1002/cpt.3453
- Publication type:
- Article
Reply to: "Questioning Conclusions and Statements on the German HTA System: A Critical Perspective".
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 24, doi. 10.1002/cpt.3452
- By:
- Publication type:
- Article
Pharmacokinetic, Safety, and Pharmacodynamic Profiles of Saroglitazar Magnesium in Cholestatic Cirrhosis With Hepatic Impairment and Participants With Renal Impairment.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 240, doi. 10.1002/cpt.3450
- By:
- Publication type:
- Article
Characteristics of Drugs from Non‐Global Companies for Hematologic Malignancies and Impact on Global Regulatory Approval.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 232, doi. 10.1002/cpt.3440
- By:
- Publication type:
- Article
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 34, doi. 10.1002/cpt.3439
- By:
- Publication type:
- Article
An Innovative Approach to Optimize First‐In‐Human Minimal Anticipated Biological Effect Level Based Starting Dose in Oncology Trials for Bispecific T‐Cell Engagers: Experience from A Solid Tumor Bispecific T‐Cell Engager.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 225, doi. 10.1002/cpt.3431
- By:
- Publication type:
- Article
A User‐Driven Framework for Dose Selection in Pregnancy: Proof of Concept for Sertraline.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 214, doi. 10.1002/cpt.3429
- By:
- Publication type:
- Article
Crossing the Chasm: How to Approach Translational Pharmacokinetic–Pharmacodynamic Modeling of Phage Dosing.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 94, doi. 10.1002/cpt.3426
- By:
- Publication type:
- Article
Population Pharmacokinetics and Exposure–Response Analysis of a Fixed‐Dose Combination of Ivermectin and Albendazole in Children, Adolescents, and Adults.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 203, doi. 10.1002/cpt.3424
- By:
- Publication type:
- Article
A Pooled Population Pharmacokinetic Study of Oral and Intravenous Administration of Clavulanic Acid in Neonates and Infants: Targeting Effective Beta‐Lactamase Inhibition.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 193, doi. 10.1002/cpt.3423
- By:
- Publication type:
- Article
Population Pharmacokinetics of Trimethoprim/Sulfamethoxazole: Dosage Optimization for Patients with Renal Insufficiency or Receiving Continuous Renal Replacement Therapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 184, doi. 10.1002/cpt.3421
- By:
- Publication type:
- Article
Neuron‐Derived Extracellular Vesicles miRNA Profiles Identify Children Who Experience Adverse Events after Ketamine Administration for Procedural Sedation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 174, doi. 10.1002/cpt.3420
- By:
- Publication type:
- Article
Prediction of the Intra‐T Lymphocyte Tacrolimus Concentration after Kidney Transplantation with Population Pharmacokinetic Modeling.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 162, doi. 10.1002/cpt.3419
- By:
- Publication type:
- Article
Partial Residual Plots as an Integrated Model Diagnostic Tool in Model‐Based Meta‐Analysis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 153, doi. 10.1002/cpt.3418
- By:
- Publication type:
- Article
Effects of Sacubitril/Valsartan on Survival in Patients with Heart Failure and Significant Valvular Heart Disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 143, doi. 10.1002/cpt.3417
- By:
- Publication type:
- Article
Towards Preanalytical Best Practices for Liquid Biopsy Studies: A BLOODPAC Landscape Analysis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 28, doi. 10.1002/cpt.3416
- By:
- Publication type:
- Article
New Biomarkers for Renal Transporter‐Mediated Drug–Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 130, doi. 10.1002/cpt.3414
- By:
- Publication type:
- Article
Comparative Analysis of Post‐Authorization Measures for Advanced Medicinal Products Authorized in the European Union and in the United States of America Between 2009 and 2023.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 73, doi. 10.1002/cpt.3410
- By:
- Publication type:
- Article
Questioning the Design of Non‐Inferiority Trials: The Strange Case for Therapeutic Drug Monitoring Absence in Phase III Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 25, doi. 10.1002/cpt.3408
- By:
- Publication type:
- Article
Regulatory Pathways for Qualification and Acceptance of Digital Health Technology‐Derived Clinical Trial Endpoints: Considerations for Sponsors.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 56, doi. 10.1002/cpt.3398
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 1, doi. 10.1002/cpt.3317
- Publication type:
- Article
Questioning Conclusions and Statements on the German HTA System: A Critical Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 1, p. 22, doi. 10.1002/cpt.3296
- By:
- Publication type:
- Article